Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
Elena PettiniGabiria PastoreFabio FiorinoDonata MedagliniAnnalisa CiabattiniPublished in: Vaccines (2021)
Characterizing the impact of the vaccination schedule on the induction of B and T cell immune responses is critical for improving vaccine immunogenicity. Here we compare the effect of a short (4 weeks) or a long (18 weeks) interval between priming and boosting in mice, using a model vaccine formulation based on the chimeric tuberculosis vaccine antigen H56 combined with alum. While no significant difference was observed in serum antigen-specific IgG response and the induction of antigen-specific T follicular helper cells into draining lymph nodes after the two immunization schedules, a longer interval between priming and boosting elicited a higher number of germinal center-B cells and H56-specific antibody-secreting cells and modulated the effector function of reactivated CD4+ T cells. These data show that the scheduling of the booster immunization could affect the immune response elicited by vaccination modulating and improving the immunogenicity of the vaccine.
Keyphrases
- immune response
- induced apoptosis
- lymph node
- dendritic cells
- cell cycle arrest
- regulatory t cells
- mycobacterium tuberculosis
- emergency department
- oxidative stress
- toll like receptor
- cell death
- stem cells
- machine learning
- hiv aids
- adipose tissue
- type diabetes
- artificial intelligence
- skeletal muscle
- cell therapy
- hepatitis c virus
- adverse drug
- preterm birth